Good day, and welcome to the II VI Fiscal Q3 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mary Jane Raymond, Chief Financial Officer. Please go ahead.
Thank you, Shelby, and good morning. I'm Mary Jane Raymond, the Chief Financial Officer here at II VI Incorporated. Welcome to our earnings call today for the Q3 of fiscal year 2021. With me today on the call are Doctor. Chuck Mattera, our Chief Executive Officer And Doctor.
Giovanni Barbarossa, our Chief Strategy Officer and the President of the Compound Semiconductor segment. This call is being recorded on Thursday, May 6, 2021. Our press release and our updated investor presentation are available on the Investor Relations tab of the website, at ii vi.com. Just as a reminder, any forward looking statements we may make today During this teleconference are given in the context of today only. They are subject to various risk factors and are subject to change possibly materially.
We do not undertake any obligation to update these statements to reflect events subsequent to today, except as required by law. A list of our known risk factors can be found in our Form 10 ks for the year ended June 30, 2020, filed in August of 2020 as well as the Form S-four filed on May 4, 2021. Our remarks today do not constitute an offer to sell or the solicitation of an offer to buy any securities. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the United States Securities Act of 1933 as amended. Finally, with respect to today's call, We will also present some non GAAP measures for which the reconciliations to GAAP are found at the end of each document that includes those measures, such as the press release or the investor presentation.
With that, let me turn it over to Doctor. Chuck Mattera.
Thanks, Mary Jane. I would like to thank you all for joining us today and for your interest in II VI. It's a time of great challenge for our world and a time of great need too. We are well aware of the opportunity we have to enable so much change And that there's nothing more difficult to take on than to lead the introduction of a new order of things. That is precisely What we have charted our course to do consistent with our vision of a world transformed through innovative materials vital to a better life today And the sustainability of future generations.
In short, we are committed to changing our world and delivering long term stakeholder value along the way. I would like to recognize our global pandemic response team and all of the II VI employees who once again mitigated the impact to our people and facilities during the quarter as the vaccines and the viruses squared off. The safety of our employees remains our top priority. With the incalculable toll and suffering from COVID-nineteen, I am grateful to the entire scientific community who developed the vaccines and who are battling heart this global pandemic now surging in India. We will keep all of the people of the world in our careers.
I also want to recognize our II VI employees We've been enabling PCR testing throughout the pandemic by supplying vital optical filters And Thermal Management Components, the makers of life science diagnostic instruments used around the world for COVID-nineteen testing and for vaccine development. Now turning to the business. Q3 was a very exciting quarter in which we continue to focus on the growth drivers of our business. As you know, on March 25, We were selected as the successful bidder for Coherent. We have known and regarded Coherent for years As pioneers of industrial laser processing and as you can see in the S-four, we have been discussing a possible strategic combination with them for some time.
Coherent will add complementary strengths to II VI with their expertise In Industrial Laser Solutions for Precision Manufacturing and a focus on the markets and applications for Life Sciences, Semi cap Equipment and Aerospace and Defense, 3 of II VI's important emerging markets. We are excited about expanding our technical resources with deep domain knowledge in laser technologies To continue to bring breakthrough solutions to the market, the combination will also expand our access to new markets and provide us an unmatched opportunity to expand our sales, service and supply chain teams to best serve customers around the world While delivering on the synergy plans. Coherent will be our largest acquisition to date and partnering with Bain Capital will be a great endeavor. Our Q3 revenue was $783,000,000 We exceeded the top end of our guidance of $780,000,000 Our revenue grew 25% year over year. We recorded a book to bill ratio of 1.08 for the quarter And we ended the quarter with a record $1,130,000,000 backlog.
We saw no signs of weakness in the demand for our Communications products and our current industry checks supported by our strong backlog underscore our view The demand will remain strong for our datacom transceivers, coherent optics and ROADM products. Although we continue to sense increased stress in our supply chain, our global supply chain team Continue to do a fantastic job of managing risk and mitigating the impact of reported supply chain shortages. Even in the face of increased demand, our shipments of transceivers, coherent optics and ROADM products We're basically unaffected by shortages as we missed less than 1% of our original sales plan for the quarter due to the supply chain. Our relatively wide Q4 guidance range for revenue reflects that the output of our transceiver business May begin to be affected by supply chain shortages. Also, we will continue to operate with an abundance of caution regarding COVID-nineteen in our locations throughout the world.
In some countries, including the U. S, Our safety protocols may constrain our output at least through Q4 in certain facilities. I believe that the scale that we have been able to achieve in the supply chain as a result of the synergies that we continue to deliver From the Finisar acquisition are serving us well. We will maintain a relentless focus on costs, Quality and lead times as well as on risk management within our diversified footprint and we will maintain a discipline about building increased redundancy and resiliency into our distributed supply chains for the long term. We are exposed to strong growth drivers implied by the mega market trends that we are enabling.
In addition to the accelerating pace of the emerging Digital transformation that we are enabling. We are pleased with the progress and positive news on many fronts, including the redefinition of a new normal in the face COVID-nineteen, increased GDP forecast and evidence of an economic recovery well underway. Looking ahead to the impact of announcements of infrastructure stimulus investments, the start of an apparent multiyear cycle in semi cap equipment, Along with the other irreversible megatrends that underpin mobile, intelligent and electric, We continue to be very excited. As one example of a possible leading indicator, during the quarter, we saw particular strength In addition, several of the AI era megatrends, including the computing end markets, are very healthy and the demand drivers continue to emerge with the proliferation of new use cases and the build up of new fabs that have been recently announced Are expected to drive the growth of our semi cap businesses. Finally, I'm proud to note that our 50th anniversary Will take place on June 22nd, and so the end of an extraordinary beginning for II VI will be here before long.
With all that excitement soon behind us, I believe that the best is yet to come as we continue to reinvent the enterprise in the face of irreversible and accelerating change. We are proud to be serving so many large innovators like Apple That are also committed to having a profoundly positive impact on the world. Their announcement yesterday about our relationship Should help clarify our sense of the importance of our long term strategic investments in disruptive technologies and products It can be manufactured at scale. The announcement by Apple yesterday focused on an award from Apple to II VI of up to $410,000,000 in future business from their advanced manufacturing fund. As Apple stated in their announcement, this will accelerate II VI's delivery of future components for iPhones.
We are enthusiastic about expanding our partnerships with market leaders like Apple to enable many of the positive changes Through the adoption of new technologies that we expect to unfold over the years ahead. We are honored to be Apple's trusted partner and we look forward to continuing our long standing relationship. With that, I'll turn it over to Doctor. Giovanni Barbarossa, our Chief Strategy Officer and the President of the Compound Semiconductors segment. Giovanni will detail Q3 and some of the key drivers of our Q4.
Giovanni? Thank you, Chuck.
The Apple announcement was indeed very exciting. We are proud that our VCSEL technology is enabling many iPhone features, Including Face ID, Memoji, Animoji and PostNet Mode selfies. In addition, as the Apple announcement stated, The LiDAR scanner allows cameras to create a 3 d map of the environment, which improves low light photography and enables more realistic augmented reality experiences. We are proud of creating hundreds of high-tech jobs in the U. S.
Through our long standing collaboration with Apple. As for our global three d sensing business this quarter, It almost doubled over the same quarter last year with a typical seasonal pattern. All facilities are qualified and shipping to multiple customers, and we are in a great position for new design wins with current and future components for the global market. In fact, we are working on expanding the technology platform for sensing With electronics drivers and the recently introduced multi junction digital and flash illumination module platforms. We expect the revenue for 3 d sensing in Q4 fiscal year 2021 to follow the usual seasonal pattern, While we're squarely focused on preparing for the ramp that will begin in calendar Q3.
Turning to the rest of our business in the quarter. Aerospace and Defense grew 16% year over year and 11% sequentially, Driven by the increasing adoption of lasers and advanced optics for a diverse set of emerging applications. Our sales and communications saw a strong customer pool across both telecom and datacom, particularly from our webscale customers. For example, Q3 was the 2nd quarter we doubled the revenue for our 204 100 gs transceivers. These are products which are experiencing a strong pull Resulting in a book to bill ratio of almost 5 and which will continue to drive our growth as the web scalers continue to move to higher data rates.
At the same time, we are positioned to lead the deployment of next generation optical interfaces at 800 gs By leveraging our enabling photonic integrated circuit platforms on both indium phosphide and silicon, which are capable of supporting 200 gs data rates by wavelength. The transformation of the optical communication market continues with carriers And data center operators accelerating the revolution towards disaggregated optical networks in order To keep pace with the forecasted market demands for bandwidth. We are excited by the market expansion opportunities For our PMA, big components, modules and integrated solutions, and we believe that we are in a leading position to continue to Enable this fast growing market. The industrial market also experienced exciting growth during the quarter. Our revenue in this market grew across all types of laser systems 24% year over year and sequentially.
And we reached an all time high revenue for our aftermarket optics in the Americas. Globally, Our aftermarket revenue reached pre pandemic records, driven by growth in fiber laser optics, CO2 laser components And customized beam delivery systems for the assembly of batteries for the largest electric vehicle manufacturers in the world. Our Life Sciences business grew sequentially for the 4th consecutive quarter, driven by demand for our optical filters, Discrete optics and thermal management solutions for a portfolio of applications, including PCR testing. This business nearly doubled year over year increasing from about 2% of total revenue a year ago to 4% this year. Sales of silicone castrate grew over 50% in Q3 compared to last year With sales to over 30 customers in various end markets, while we continue to make steady progress in building our device and module business and accelerating our multiyear capacity expansion.
Our semiconductor capital equipment product lines are sold out On all of our Engineered Materials products for both the front end and the back end of the line, and our sales into this market grew 15% sequentially. We continue to expand our manufacturing capacity ahead of the accelerating demand deriving from the multiyear investment cycle, which is globally underway. The GDP growth that Chuck referenced earlier is coming from both North American and Asian markets. To support this growth, we opened a new technology and R and D center in Shanghai, which we inaugurated last month. We also opened our applications lab for laser material processing in Suzhou to better serve a growing number of industrial customers in China.
Finally, we expanded our global silicon carbide wafer processing operations by opening a wafer finishing line on our Fuzhou campus To better serve the growing electric vehicle market globally, including in China, which is expected to be the largest market for electric vehicles. Finally, many of our large strategic customers are asking us to accelerate our investments in compound and other factors including for our exciting silicon carbide based white bandgap platforms. Accordingly, we anticipate adding over 300 jobs to our global R and D team over the next 12 to 18 months With over 150 of those positions in the U. S. With that, let me turn it over to Mary Jane.
Mary Jane?
Thank you, Giovanni, and good morning. First, in case you missed it, II VI was recently recognized by Forbes as one of the best Midsize Companies in America. Thank you, Forbes. I'd also like to thank my colleagues around the world for their remarkable efforts to keep our factories and fabs humming in these challenging times. Thank you very much.
Turning to the quarter. Our non GAAP gross margin was 38.9% and the non GAAP operating margin was 18%. The non GAAP gross margin and the non GAAP operating margin remain well ahead of the margins 2.6% reported right before the acquisition of Finisar closed. COVID expenses incurred in the quarter to maintain safe workplaces were $5,500,000 of which about $2,000,000 is included in non GAAP. This total includes lost work time, and collectively, these costs put downward pressure At the segment level, the non GAAP operating margins were 14.7% for Photonics And 24.2 percent for compound semiconductors.
Similar to last quarter, compound semis margins were driven Our record backlog of $1,130,000,000 consists of $750,000,000 in Photonics $380,000,000 in compound semiconductors. The backlog contains orders that will ship over the next 12 months. GAAP operating expenses, which are SG and A plus R and D were $214,000,000 Excluding $21,000,000 of amortization, dollars 14,000,000 of stock comp and $17,000,000 of M and A and integration costs, Non GAAP OpEx was $163,000,000 or 21 percent of revenue and over 500 basis points below the OpEx percent of revenue just prior to the close of the acquisition when it was nearly 26% for II VI and Finisar combined, excluding amortization, stock comp and transaction costs. These improvements are driven by our accelerated achievement of synergies and our ongoing cost control. Quarterly GAAP EPS was $0.66 and non GAAP EPS was $0.91 with after tax non GAAP adjustments of $30,000,000 in total.
The diluted share count for the GAAP results was 116,000,000 shares. For non GAAP, the diluted share count was 125,000,000 shares. The GAAP and non GAAP EPS calculations are in the last two tables of the press release. Stock comp was $17,000,000 for the quarter, dollars 3,000,000 in COGS and $14,000,000 in OpEx. We expect stock comp for Q4 to be $18,000,000 Cash flow from operations in the quarter was $91,000,000 And free cash flow was $64,000,000 We paid down $75,000,000 of our debt in addition to the required payment of 15,000,000 In Q3, our net debt position moved to a net cash position of $79,000,000 The interest expense in the quarter was $13,000,000 Capital expenditures this quarter were 26,000,000 For the year, we expect CapEx to be between $170,000,000 to $190,000,000 to support our forecasted growth, particularly in compound semiconductors.
Depreciation was $47,000,000 in the quarter and we expect Our forward depreciation expense to be about $48,000,000 a quarter. FX was a gain in the quarter of $7,900,000 primarily driven by the Swiss franc and the Malaysian ringgit. This is a reversal of the first half of fiscal year 'twenty one trading in these two currencies. The effective tax rate in the quarter was 13% due to receiving renewed high-tech status in several countries. We expect the tax rate to be between 16% 19% for the year, making the Q4 tax rate between 20% 22%.
The tax rate to be used for the non GAAP items is 19%. The tax rate expectation is reduced From our prior range of 18% to 22% due to renewals of Hy Tech status, which we cannot include until they are in hand, Super R and D deductions, increased stock option exercises and changes in mix and income around the world. We had $18,500,000 in total costs for M and A, integration and other costs, largely for Coherent and Sinasar. With respect to our Series B preferred stock issuance, we are very, very happy for our new partnership with Bain. We look forward to their advice and counsel as we go forward.
II VI has already received $750,000,000 of the committed Bain Capital Investment of $1,800,000,000 in the form of preferred equity. This investment carries a 5% annual dividend Paid in cash and capitalized the principal for the 1st 4 years. This drives a $10,200,000 dividend in Q4 That will be deducted from the net income in the same manner that the $6,900,000 dividend is deducted for the Series A preferred stock. In Q3, the Bain investment had a mark to market gain of $11,000,000 For the changes in our stock price during the period between the signing of our agreement and the receipt of the funds. Now that the first tranche of funds has been received, this will not repeat.
Turning to the outlook on Q4. Our record backlog and yesterday's announcement by Apple indicate continued strong demand trends. Our fiscal year 2021 outlook is ahead of our original budget, including our having to replace about 5% of our budgeted consolidated revenues for the whole year due to the restrictions on Huawei. We did that within 3 quarters. For Q4, our wider guidance range simply reflects an extra measure of caution related To the supply chain risks, which have increased in the last few months and the potential impact of our continued rigorous COVID-nineteen protocols, which could affect our ability to convert some of our work in process inventory to finished goods by year end.
Our outlook for revenue for the Q4 ending June 30, 2021 is expected to be $752,000,000 to $802,000,000 and earnings per share on a non GAAP basis at $0.63 to $0.83 at 118,000,000 shares. For Q4, we expect both the Series A And the Series B preferred stock to be anti dilutive. This EPS range includes the deduction Of the $10,200,000 of the Bain dividend from the net income and accounts for about 0 point exchange rate and an estimated tax rate of 21%. For the non GAAP earnings per share, we add back to the GAAP earnings Pretax amounts of $21,000,000 in amortization, dollars 18,000,000 in stock comp and $12,000,000 in transaction and integration costs. The estimated Q4 share count is 111,000,000 shares for GAAP and 118,000,000 for non GAAP.
The actual dollar amount of non GAAP items, the tax rate, the exchange rates and the share count are all subject to change. Before we go to the Q and A, just as a reminder, our answers today may contain forecasts from which our actual results may differ due to a variety of factors, including, but not limited to, changes in product mix customer orders Supply chain shortages, both upstream and downstream competition changes in regulations ongoing requirements to combat COVID-nineteen virus And general economic conditions. We would also ask that each firm limit its questions to one question with no follow-up As we would like to try and get everyone in during the call today, we expect to end this call at 10 am. Shelby, you may open the line for questions.
Thank We'll take our first question from Jud Dorsheimer with Canaccord Genuity.
Thanks. I guess Given that I only have one question and assuming somebody else will ask on the impact and quantifying It's on the supply chain. I guess my question would be more strategic around the value proposition on the Both the Gallium Nitride as well as that of the indium phosphide. And specifically, it seems for indium phosphide that most of The driving force is in optical and yet the 1550 presents an opportunity from a near eye application. So When do you see that starting to materialize?
And similarly on the gallium nitride, The value proposition moving from PAs and base stations to lower voltage devices.
Hey, Jade. Hi. Thanks for your question. This is Giovanni. Absolutely, The indium phosphide was one of the weaker gens in Finisal, which made the very our position so valuable.
And we expect the indium phosphide platform to take off, I would say, at least A year from now, maybe a year and a half from now with a number of applications, and we are working very hard on them. We are Investing heavily in, as I mentioned, in R and D. Also, with respect to that platform and likewise, Gallium Nitride, We continue with our partnership with Sumitomo to make progress to qualify our 6 inches line in Warren, New Jersey. So we think that by the mid of next fiscal year, we'll see some impact on our growth.
Actually, for all of you, just before we turn to the second question, please let me correct something. I had a small misspeak. With respect to the Series B preferred stock, the investment carries a 5% dividend that's paid in stock and capitalized to the principal for the 1st 4 years. So sorry for that misspeak. Okay, go ahead, Shelby.
Thank you. We'll take our next question from Paul Silverstein with Cowen.
Yes. Guys, The numbers you all put in the proxy that you showed coherent for fiscal 2022 in particular, If I remember, it's about 4% top line growth that the revenue represented. Any insight you can give That lies behind what would seem to be given all the drivers you're looking at and their impact, It's on its face, it appears to be a very soft number. Any insight you can provide?
Sure. Hi, Paul. It's Mirajane. First of all, we RS4 projection includes lots of Evaluations of opportunities and risk, whether it be the pandemic, supply chain shortages, trade restrictions and several other things like that, All of those factors were present this year and present when we did our budget. For fiscal year 2021, it would be fair to say that we have probably successfully Several of those, but all of them have not gone away.
And so we have many of these risks, if not other ones, presenting themselves in fiscal year 22. As we are working on the 2022 budget now, and we, like our colleagues, give quarterly guidance. This is why the Projections are not meant to be guidance. And I would say as the company looks at those risks going forward, we will be doing our very best to be seeing what we can do To offset them as we go forward as we did in 2021.
We'll take our next Question from Anadha Baruah with Loop Capital.
Hi, good morning guys. Really appreciate you taking the question. This may end up being more of a clarification of Giovanni's earlier remarks, but just the conversation that's begun around 3 d sensing VCSEL technology becoming more integrated, the use of integrated VCSEL technology, would love to get your perspective on how the company views Integrated VCSEL Technology, and if you view involvement of this favorably. And if so, what your Perspective on roadmap for marketplace involvement may be Giovanni made a remark that I missed partially about the Flood Illuminator and it sounded like maybe integration, but I wanted to just sort of clarify that and get your thoughts on that. Really appreciate it.
Thanks, Ananda. This is Giovanni here. Thanks for your question. Obviously, This is the investment we started years ago with our vertically integrated 6 inches platform On gallium arsenide for VCSEL is meant to be just the beginning of a journey to enable Next generation augmented reality, virtual reality and generally speaking new applications for Consumer Electronics Products. And we as I said during the prepared remarks, We doubled the revenue this quarter over last year.
And as you know, the market did not double. So clearly, we have been gaining share. We are gaining share. We will continue, I expect, to continue share To grow share gain share over the next few quarters and the next years. And that will derive essentially from really innovation.
We have announced a multi junction VCSEL family Our products, we started with 2, we go to 3, we'll eventually go to a larger number of junctions to increase the power of the VCSELs. We have announced Illumination modules, platforms, where we can integrate the VCSELs with some defective optics that we make in house. So we have a very attractive road map. So it should come clearly as a no surprise when you see Apple Announcing a collaboration and making it public with regard to future components.
And we'll take our next question from Harsh Kumar with Piper Sandler.
Yes. Hey Mary Jane, I wanted to clarify something. You said that the Series Hey, and we also was anti dilutive. Did I hear that correctly? How does that We don't see these things very often in our books.
How does that work? And then is that $0.09 sort of Partly built into the $0.63 on the GAAP guidance, how is that guidance?
So the first of all, the way that the EPS calculation goes for Q3 from an actual point of view It's in the press release. And so when we have a security and in the Q4 guidance, we do expect the Series A and the Series B to be anti dilutive. What happens then is that you deduct the dividend from the net income to reach Net income available to the common shareholders. And then you the shares that are used are the ones that are The common shares outstanding plus any other shares, for example, stock comp or the convertible debt that are dilutive. And so in this case, In the Q3, for example, on the Series A, because it was dilutive, you add back the 6.9 and you add the shares, that's why the shares are 125.
When it's antidilutive, you do not add back the dividend and you do not add in the shares. That's why the non GAAP shares for Q4 are at 118. And yes, the $0.09 is in the guidance range.
We'll take our next question from John Marchetti with Stifel?
Thanks very much. Mary Jane, if you could just spend a moment or 2 going through some of the puts and takes in the gross margin line this quarter, Down a little bit more sequentially than certainly we had expected. You did mention some of the charges that you took around Some of the COVID related issues, curious if that whole $2,000,000 that you mentioned in non GAAP is in that line, but just any color that you can give us on gross margin would be helpful.
Yes. So, first of all, the total amount of cost, if I look across the whole company at everything we're doing, Including how if we have a person unfortunately testing positive, we ask them to quarantine, which leads to lost time. Those total costs were about $5,500,000 and that I would say that the vast majority of that, at least 90% of it, is in the gross margin Because in our company, every factory, I believe it would be correct to say that Our colleagues that are working every day in the operations are considered essential. So they are actually coming into work and interacting with others, whereas most of the people in G and A and R and D are working from home still. So that I would say did have some the entire $5,500,000 had downward pressure on the gross margin, the $2,000,000 that we non GAAP was an attempt to try and look at what do we think is the unusual amount in the quarter because there probably is an amount of COVID cost that will go on for some time.
So that is one thing that is, was increased in the quarter. That's a fair thing to say. I think the second thing is that Notwithstanding that compound semiconductors had a very nice mix in the quarter, at the end of the day, they certainly Had some somewhat lower mix in the quarter and so did Photonics. So mix had a lot to do with the quarter. If you remember, Last quarter, a significant part of the revenue was in 3 d sensing because that's the high quarter for 3 d sensing.
And in this quarter, we had, I would say, more of A more moderated mix of everything in the quarter notwithstanding that we're also seeing industrial pickup. So those are really the main puts and takes, I would say, for the Q3.
We'll take our next question from Simon Leopold with Raymond James.
Thank you very much for taking the question. I wanted to see if I could get a little bit more help understanding The Apple announcement yesterday in terms of the commitment and appreciate what you've laid out. I wonder if maybe you could Compare and contrast the announcement they made yesterday to what they announced with Finisar back in December 2017. How are these different? And I guess what I'm the conclusion I'm leaping to is that this should be thought of As a promise or purchase order commitment and so it does outline some sense of what they'll buy from you in the future over some undetermined time.
If you could help us with that. Thank you.
Hi, Simon. Thanks for your question. This is Giovanni. Yes, absolutely. As The announcement clearly says it's for future components for iPhone.
So Clearly, there is a commitment for future business. And again, it's around specifically Future components. So I think the if you want, it's a continuation of what was done with Finisar in a way. But I think this announcement is probably a little bit more clear than the previous announcement. And so I think the we are very thankful to the Apple leadership to Announce this in the public domain and give us the ability to talk about it.
We'll take our next question from Mark Miller with Benchmark Company.
Just curious about The increases in SG and A and also other income, was that the gain from the main investment?
Yes. So first of all, let's do the latter. In other income and expense this quarter, we had 2 positives, both of which come out in non GAAP. One, the FX was positive in the quarter after 2 quarters of it being negative. And the second one was the $11,000,000 increase for Mark to market recording for the Bain Securities.
So that's correct, Mark. Then with respect to the increase in SG and A, If you remember last quarter from an M and A point of view, we did not have too, too much in our integration costs coming out. But this quarter, we had Just for Coherent alone, it was $15,000,000 of cost for that pending acquisition.
We'll take our next question from Dave Kang with B. Riley.
Good morning. My question is going back to that proxies of forecast. So what about fiscal 'twenty three? Fiscal 'twenty two, you're providing fairly conservative forecast, but 23%, I believe it's like 20%. So what's driving that 20% type of I'm not saying 20%, but much stronger growth In fiscal 2023 versus 2022?
So again, let's just review this. First of all, with respect to the end markets we are serving, All of our comments that we said today remain in place. We are seeing ourselves right at the cusp of serving some really wonderful future mega revenue trends. So in the preparation for the 5 year plan for the forecast that were done, One of the things we looked at when we were preparing these, just say take the 'twenty one budget as a part of that, We had a lot of things moving in the world, whether that be COVID just starting, trade restrictions that were new and growing and uncertain election, etcetera, etcetera. And as I said, We said that we expected we did successfully offset those pretty well in fiscal year 2021, but our thinking is that those do not really go away and could present themselves in this near term as in 2022.
And so we have work underway and that's what's going on right now To figure out how we will deal with that and continue to deliver 426. That said, we still see very, very strong growth drivers going forward. So When you look at the projections, if you think about them in terms of the opportunities that are available to II VI, we have a lot of very wonderful opportunities ahead of
We'll take our next question from Richard Shannon with Craig Hallum.
Well, thanks guys for taking my question. Maybe a 2 parter within communications. A couple of comments, very interesting ones from Giovanni. You called out some Strength here in datacom, which is not necessarily surprising, but a very strong book to bill. I think I heard you say 5 times.
If you can confirm that, that would be helpful in helping to understand Where that's coming from including share gains and telecom seems to be a little bit softer and get 2.6% is doing well here. Can you help us understand where you're seeing that different than others. Thank you.
Hey, Shafan. Hi, thanks. This is Joao. Thanks for your question. Yes, absolutely.
I did say 5, but it's specific to the 200 gs and 400 gs transceivers. So clearly, I think we are getting back on track after the almost a year of Standby of the Finisar team waiting for the Chinese approval.
A lot of
customers remain on the sideline waiting For the combination to take place, and I think now we are gearing up and going much faster than the market, right, because clearly, The book to bill ratio is an indication of that. So it's an indication of, yes, I believe gaining share is an indication of The performance, the differentiation of the platforms and The strength, as I said in the prepared remarks, is actually across the board. We just wanted to highlight those 2 because those are really Enabling the next generation deployment particularly for the webscale customers.
We'll take our next question from Jim Ricchiuti with Needham and Company.
Hi, good morning. I just wanted to follow-up on some of the comments on component constraints. I'm wondering how you're thinking about Supply chain issues, potentially looking out beyond the June quarter, are you more concerned by what you're seeing out there? And Do you see any signs of potential double ordering in this kind of environment? Thank you.
Okay. Hey, good morning, Jim. This is Chuck. Thanks for your question. Good morning.
Thanks for your question. Coming back to some of the related questions about the future And the demand we feel like the demand is continuing to be strong. As far as the supply chain goes, When we put our long range plan together and while we're currently reevaluating even in the near term, We've taken a very cautious assessment about the near term and we think that we're justified to do that And we must do that. We've been operating very successfully inside the bounds of a once in a 100 year global pandemic. We've also done one heck of a job managing the supply chain, but it's not only our Ability to manage the supply chain that we have to stay focused on, we're looking 1 and 2 steps downstream from us.
And we have to be mindful that even though the demand environment is feeling very, very strong Our customers and their customers also have to operate inside this very complex global supply chain. And by the way, when the Intel CEO says that chip shortages will persist for a couple of years, We have to pay attention to that. And so our ability to manage through this, I feel very confident we have the very best team in the world to do it. And I think that we can begin to feel this as we started the quarter, we had a little bit more of a challenge as we started the quarter this quarter Than we had the last couple of quarters. I got great confidence in our team, but there's only so much that they can do.
And so we will play this Every quarter, we will do a very, very aggressive look. We manage this business day by day, month by month, and we have our heads on a swift About what we need to do to keep everything on the track that we're on. Okay. I'm really excited about it, Jim. It's
We'll take our next question from Christopher Rolland with Susquehanna.
Thanks, guys. And Chuck, this might be a follow-up for you. I'm trying to put all the pieces together here. Your backlog was Fairly flat here. It sounds like you have some additional constraints that would grow backlog, Stuff like Finisar transceivers, I think.
If you want to talk about any other areas of constraint, growing backlog, that would be great. But then given your fairly flat backlog, what areas are actually loosening up for you as well that You're able to fill. Yes, just that high level perspective of backlog, just where you still have constraints and where you're able to fulfill fully?
Well, every manufacturing line has constraints. Whoever runs the constraints and controls and runs the business. So our whole ability to be able to maximize the yielded throughput through the constraints is our main focus. We have lots of factories, lots of manufacturing lines. We have a common discipline toward constraint management across the company.
I don't think I'm going to be able to articulate for you every one of the constraints. If you say where do we have any excess capacity, There's not a lot of it hanging around. And that's why we have been investing in capital and we will continue to invest And capital and capacity to enable us both to break the constraints and to be ready to launch new products and new platforms to drive the growth From 2022 and beyond.
We'll take our next question from Meta Marshall with Morgan Stanley.
Great. Thanks and congrats on the quarter. Mary Jane, I just wanted to spend a second on the EPS outlook On a similar kind of volume to fiscal Q3, and so I understand the commentary you gave around the preferred shares and But are there any other factors we should be considering that are more fiscal Q4 specific like bonus true ups Or is some of this just mix of the businesses we step from fiscal Q3 to fiscal Q4? Thanks.
Sure. Well, I think if you think about our remarks, on the one hand, with respect to various things about Supply chain, COVID, etcetera, we are probably taking a bit of a Conservative approach as we look at Q4 given the various things we could encounter and the EPS It's a little bit of a reflection of also the wide range, we have in the revenue guidance. It is true, Meta, that it is our year end. We do sometimes have true ups at that for, say, compensation. We recognize, for example, that happened last year.
So we have been working to not have that be too remarkable. But at the end of the day, There could be a little bit of that certainly as we finish out the year. I would say the main thing though really is that Should we see spikes from a COVID point of view, that drives some costs, but it's really more of the shortages that Could just drive inefficiency in the company in Q4. Now having said that, as you can see for all of our other quarters, we work very, very hard To offset those, we also try our very best to anticipate by being extremely paranoid before it even starts. But there are, as Chuck was indicating, growing shortages in some parts of our components that could make And a little bit challenging, as I noted, in terms of just the basic moving work in process inventory to finished goods to be able to sell it.
And notwithstanding Chris' comment earlier that the backlog was pretty flat, there's certainly people in our company that think that backlog contains revenue we should be shipping already. Our focus is to really deliver to our customers' needs.
We'll take our last question from Michael Genovese with Westpark Capital.
Great. Thanks very
much. It doesn't sound like there's been a change, but I just would like any comments On expected regulatory approval for the Coherent deal, how that process is going. And then if you could just clarify for me, I'm confused about the preferred dividend, if it repeats Beyond the Q4, and if it does, how often?
Right. So first of all, With respect to the filings going as planned, we're already filed in the United States. We're in process for the other jurisdictions. The S-four is app, as you've already seen that. And then with respect to the dividend, oh, certainly.
It's a quarterly dividend, so it's 5% a year and is calculated and accumulated quarterly. And as I said, it's stock paid and capitalized to the principal For the 1st 4 years. So yes, the dividend is every quarter same in the Series B, same as it is for the Series A.
That concludes today's question and answer session. At this time, I will turn the conference Back over to the speakers for any additional or closing remarks.
Thank you, Shelby, very, very much. Before we end our call today, We'd like to invite all of you to the II VI Advanced Markets and Technologies event to be held virtually on May 20 from 10 o'clock in the morning to noon Eastern U. S. Time. We'd love to have all of you there.
Thank you so much for joining us today, and have a good day.
This concludes today's call. Thank you for your participation. You may now disconnect.